Optimization of an Experimental Vaccine To Prevent Escherichia
Por um escritor misterioso
Descrição
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs: Trends in Pharmacological Sciences
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines
Modeling Framework for Vaccine Production - BioProcess InternationalBioProcess International
Microorganisms, Free Full-Text
In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis - Computational and Structural Biotechnology Journal
Vaccines, Free Full-Text
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use - Cytotherapy
PDF) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection
Preventing the next pandemic - MIT Science Policy Review
Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories
Optimization of an Experimental Vaccine to Prevent Escherichia coli Urinary Tract Infection
de
por adulto (o preço varia de acordo com o tamanho do grupo)
